GIM
ABMD

Granahan Investment Management’s Abiomed Inc ABMD Stock Holding History

Granahan Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,260
Closed -$3.27M – 209
2021
Q1 		$3.27M Sell
10,260
-2,792
-21% -$894K 0.07% 158
2020
Q4 		$4.23M Buy
+13,052
New +$3.61M 0.1% 141
2020
Q3 		– Sell
-3,802
Closed -$919K – 208
2020
Q2 		$919K Sell
3,802
-17,836
-82% -$3.58M 0.03% 170
2020
Q1 		$3.14M Buy
21,638
+12,911
+148% +$2.14M 0.17% 110
2019
Q4 		$1.49M Sell
8,727
-376
-4% -$69.7K 0.07% 148
2019
Q3 		$1.62M Sell
9,103
-11,097
-55% -$2.4M 0.09% 145
2019
Q2 		$5.26M Sell
20,200
-599
-3% -$159K 0.26% 85
2019
Q1 		$5.94M Buy
20,799
+13,334
+179% +$4.43M 0.32% 84
2018
Q4 		$2.43M Buy
+7,465
New +$2.59M 0.17% 120
2018
Q2 		– Sell
-12,317
Closed -$3.58M – 227
2018
Q1 		$3.58M Sell
12,317
-72,245
-85% -$18.3M 0.26% 113
2017
Q4 		$15.8M Sell
84,562
-48,373
-36% -$9.03M 1.25% 19
2017
Q3 		$22.4M Sell
132,935
-7,451
-5% -$1.13M 1.87% 6
2017
Q2 		$20.1M Buy
140,386
+19,421
+16% +$2.61M 1.85% 8
2017
Q1 		$15.1M Sell
120,965
-451,718
-79% -$52.4M 1.52% 11
2016
Q4 		$64.5M Buy
572,683
+271,600
+90% +$31.5M 2.22% 1
2016
Q3 		$38.7M Sell
301,083
-20,700
-6% -$2.48M 1.27% 13
2016
Q2 		$35.2M Sell
321,783
-600
-0.2% -$59.7K 1.28% 10
2016
Q1 		$30.6M Buy
322,383
+33,400
+12% +$2.82M 1.11% 17
2015
Q4 		$26.1M Buy
288,983
+211,675
+274% +$18M 0.9% 30
2015
Q3 		$7.17M Buy
77,308
+38,808
+101% +$3.42M 0.22% 146
2015
Q2 		$2.53M Buy
+38,500
New +$2.56M 0.07% 207

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Granahan Investment Management's ABMD Position: Q2 2021 in Review

Granahan Investment Management sold out of Abiomed Inc (ABMD) in Q2 2021, closing a stake of 10,260 shares — an estimated $3.27M sold.

Granahan Investment Management first reported a position in ABMD in Q2 2015 and held it in 21 quarters. The position peaked at $64.5M in Q4 2016. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • Granahan Investment Management reported no remaining Abiomed Inc position as of Q2 2021 after selling out during the quarter.
  • Granahan Investment Management sold 10,260 Abiomed Inc shares in Q2 2021, an estimated $3.27M.
  • Granahan Investment Management first reported a position in Abiomed Inc in Q2 2015 and held it in 21 quarters.
  • Granahan Investment Management's Abiomed Inc position peaked at $64.5M in Q4 2016.
  • 474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on Granahan Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.